- Title:
New Corporate Video and Investor Webinar - Time:
07:00:09 - Date:
6 Jul 2020 - Category:
Corporate updates - ID:
0575S
6 July 2020
Hemogenyx Pharmaceuticals plc
("Hemogenyx Pharmaceuticals" or the "Company")
New Corporate Video and Investor Webinar
Hemogenyx Pharmaceuticals plc (LSE: HEMO), the biopharmaceutical group developing new therapies and treatments for blood diseases, is pleased to announce that a new corporate video is available to view on the Company's website and can be accessed by following the link:
https://youtu.be/LP95GWupyNA
In addition, the Company also announces that Dr Vladislav Sandler, Chief Executive Officer & Co-Founder of Hemogenyx Pharmaceuticals will host a live investor webinar on 20 July 2020 at 16:00 UK time at which he will answer questions about the Company's current activities. If you would like to register for the webinar, please follow this link:
https://us02web.zoom.us/meeting/register/tZIocuyrqj4pH9HRgZuobXLJdSDkRXUDFRDU
After registering, you will receive a confirmation email containing information about joining the meeting.
Please submit your questions in advance and not later than 17 July 2020 by emailing [email protected].
Enquiries:
| Hemogenyx Pharmaceuticals plc |
www.hemogenyx.com |
| Dr Vladislav Sandler, Chief Executive Officer & Co-Founder |
|
| Peter Redmond, Director |
|
| |
|
| |
|
| SP Angel Corporate Finance LLP |
Tel: +44 (0)20 3470 0470 |
| Matthew Johnson, Vadim Alexandre, Soltan Tagiev |
|
| |
|
| |
|
| Peterhouse Capital Limited |
Tel: +44 (0)20 7469 0930 |
| Lucy Williams, Duncan Vasey, Charles Goodfellow |
|
| |
|
| |
|
| US Media enquiries |
Tel: +1 (323) 646-3249 |
| Lowell Goodman |
New Corporate Video and Investor Webinar07:00:096 Jul 2020Corporate updates0575S